Iran's Burden of Disease and Burden of Data Collection

Iran's Burden of Disease and Burden of Data Collection – Authors' Reply Publisher Pubmed

Sepanlou SG^{1, 4} ; Moghaddam SS² ; Farzadfar F² ; Malekzadeh R^{1, 4} ; Larijani B³ ; Weaver ND⁵ ; Naghavi M^{5, 6}

Show Affiliations

1. Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
2. Non-Communicable Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran
3. Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran
4. Non-Communicable Disease Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
5. Institute for Health Metrics and Evaluation, School of Medicine, University of Washington, Seattle, 98195, WA, United States
6. Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, 98195, WA, United States

Source: The Lancet Published:2022

Abstract

[No abstract available]

Related Docs

View other Related Docs

1. Burden of Road Traffic Injuries in Iran: A National and Subnational Perspective, 1990-2019, Injury Prevention (2023)

2. National and Sub-National Burden and Trend of Type 1 Diabetes in 31 Provinces of Iran, 1990–2019, Scientific Reports (2023)

3. “Current Incidence of Injuries in Iran; Findings of Steps Survey 2021”, Heliyon (2023)

4. Neonate, Infant, and Child Mortality by Cause in Provinces of Iran: An Analysis for the Global Burden of Disease Study 2019, Archives of Iranian Medicine (2022)

5. Prediction of Human Health Risk and Disability-Adjusted Life Years Induced by Heavy Metals Exposure Through Drinking Water in Fars Province, Iran, Scientific Reports (2023)

6. National, Sub-National, and Risk-Attributed Burden of Thyroid Cancer in Iran From 1990 to 2019, Scientific Reports (2022)

7. Epidemiology, Burden, and Attributable Risks of Infective Endocarditis in Iran and Its Provinces: From 1990 to 2019, International Journal of Cardiology (2022)

8. Effect of the Chronic Medication Use on Outcome Measures of Hospitalized Covid-19 Patients: Evidence From Big Data, Frontiers in Public Health (2023)

Experts (# of related papers)

View all Related Experts

Farshad Farzadfar (13)

Bagher Larijani (12)

Style	Citing Format
MLA	Sepanlou SG, et al.. "Iran's Burden of Disease and Burden of Data Collection – Authors' Reply." The Lancet, vol. 400, no. 10351, 2022, pp. 490-491.
APA	Sepanlou SG, Moghaddam SS, Farzadfar F, Malekzadeh R, Larijani B, Weaver ND, Naghavi M (2022). Iran's Burden of Disease and Burden of Data Collection – Authors' Reply. The Lancet, 400(10351), 490-491.
Chicago	Sepanlou SG, Moghaddam SS, Farzadfar F, Malekzadeh R, Larijani B, Weaver ND, Naghavi M. "Iran's Burden of Disease and Burden of Data Collection – Authors' Reply." The Lancet 400, no. 10351 (2022): 490-491.
Harvard	Sepanlou SG et al. (2022) 'Iran's Burden of Disease and Burden of Data Collection – Authors' Reply', The Lancet, 400(10351), pp. 490-491.
Vancouver	Sepanlou SG, Moghaddam SS, Farzadfar F, Malekzadeh R, Larijani B, Weaver ND, et al.. Iran's Burden of Disease and Burden of Data Collection – Authors' Reply. The Lancet. 2022;400(10351):490-491.
BibTex	@article{ author = {Sepanlou SG and Moghaddam SS and Farzadfar F and Malekzadeh R and Larijani B and Weaver ND and Naghavi M}, title = {Iran's Burden of Disease and Burden of Data Collection – Authors' Reply}, journal = {The Lancet}, volume = {400}, number = {10351}, pages = {490-491}, year = {2022} }
RIS	TY - JOUR AU - Sepanlou SG AU - Moghaddam SS AU - Farzadfar F AU - Malekzadeh R AU - Larijani B AU - Weaver ND AU - Naghavi M TI - Iran's Burden of Disease and Burden of Data Collection – Authors' Reply JO - The Lancet VL - 400 IS - 10351 SP - 490 EP - 491 PY - 2022 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract